R-03201195
Based on 1 publication(s) in Google Scholar
R-03201195 is an efficient and selective p38 MAP kinase inhibitor with an IC50 for p38α of 0.7 nM. R-03201195 has inhibitory activity against TNF-α in THP-1 cells and against IL-1β in human whole blood, with IC50 values of 0.25 and 0.57 nM respectively. R-03201195 can be used for inflammatory diseases such as rheumatoid arthritis.
For research use only. We do not sell to patients.
- CAS No.: 249936-55-8
- Formula: C19H18FN3O4
- Molecular Weight:371.36
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) R-03201195
More
Biological Activity
|
p38 MAP kinase |
IL-1β |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| THP-1 | IC50 |
0.25 μM
Compound: 63
|
Inhibition of LPS-induced TNFalpha production in THP1 cells
Inhibition of LPS-induced TNFalpha production in THP1 cells
|
[PMID: 16509574] |
| THP-1 | IC50 |
250 nM
Compound: Ro-3201195
|
Inhibition of p38alpha-induced TNFalpha production in human THP1 cells
Inhibition of p38alpha-induced TNFalpha production in human THP1 cells
|
[PMID: 18539026] |
Chemical Information
-
CAS No. 249936-55-8
-
Molecular Weight 371.36
-
Formula C19H18FN3O4
-
SMILES
OC[C@H](O)COC1=CC=CC(C(C2=C(N)N(C3=CC=C(F)C=C3)N=C2)=O)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Front Med
Wogonoside alleviates hyperosmotic stress-induced inflammation and apoptosis in human corneal epithelial cells via PI3K/AKT signaling. [Abstract]2026 May 4:13:1828021. PMID: 42210954
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)